发明名称 |
Treatment of neurological disorders |
摘要 |
A treatment of a neurological disorder, including hypoxia, oxygen-glucose deprivation and acute brain trauma in a subject involves administering an effective amount of selenate or a pharmaceutically acceptable salt thereof to the subject. The treatment prevents incurring a symptom, holds in check a symptom or treats an existing symptom of the neurological disorder. |
申请公布号 |
US9415063(B2) |
申请公布日期 |
2016.08.16 |
申请号 |
US201514842650 |
申请日期 |
2015.09.01 |
申请人 |
VELACOR THERAPEUTICS PTY LTD. |
发明人 |
Morley Grant;Hovens Christopher |
分类号 |
A61K31/12;A61K31/135;A61K31/15;A61K31/165;A61K31/198;A61K31/275;A61K31/428;A61K31/46;A61K31/48;A61K33/04;A61K33/06;A61K31/137;A61K31/4453;A61K31/473;A61K31/4985;A61K45/06 |
主分类号 |
A61K31/12 |
代理机构 |
Knobbe, Martens, Olson & Bear LLP |
代理人 |
Knobbe, Martens, Olson & Bear LLP |
主权项 |
1. A method for the treatment of traumatic brain injury in a subject comprising administering an effective amount of selenate or a pharmaceutically acceptable salt thereof, wherein the treatment prevents incurring a symptom, holds in check a symptom or treats an existing symptom of said traumatic brain injury. |
地址 |
Parkville AU |